🔎 Trials Near Me

Hem › Äggstockscancer › Indiana

Kliniska studier för Äggstockscancer i Indiana

23 studier för Äggstockscancer söker deltagare vid platser i Indiana.

Städer i Indiana

Officiell studietext (engelska)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • UChicago Medicine Northwest Indiana, Crown Point
  • Woodland Cancer Care Center, Michigan City
RekryterarFas 2
Alla åldrar · Alla kön · Uppdaterad 2 okt. 2026 · NCT05564377

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • IU Simon Cancer Center, Indianapolis
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT06465069

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

  • Site 0284 - Community Cancer Center North, Indianapolis
  • Site 0217 - St Vincent Hospital and Health Care Centers, Indianapolis
RekryterarFas 2
Ålder 18 och äldre · Kvinnor · Uppdaterad 29 sep. 2026 · NCT05128825

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

  • Parkview Research Center /ID# 274338, Fort Wayne
  • Indiana University Melvin and Bren Simon Cancer Center /ID# 275492, Indianapolis
RekryterarFas 2
Ålder 18 och äldre · Kvinnor · Uppdaterad 29 sep. 2026 · NCT06890338

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Community Health Network, Indianapolis
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT06128551

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07213804

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • Indiana University (IU) School of Medicine, Indianapolis
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07213791

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

  • Parkview Research Center at Parkview Regional Medical Center ( Site 0055), Fort Wayne
  • Franciscan Health Indianapolis ( Site 0081), Indianapolis
RekryterarFas 3
Ålder 18 och äldre · Kvinnor · Uppdaterad 17 sep. 2026 · NCT07318558

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • Parkview Research Center, Fort Wayne
RekryterarFas 2
Ålder 18 till 99 · Kvinnor · Uppdaterad 15 sep. 2026 · NCT07023627

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

  • Parkview Research Center at Parkview Regional Medical Center ( Site 0003), Fort Wayne
RekryterarFas 3
Ålder 18 och äldre · Kvinnor · Uppdaterad 3 sep. 2026 · NCT06824467

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

  • Indiana University Simon Comprehensive Cancer Center, Indianapolis
RekryterarFas 3
Ålder 18 och äldre · Kvinnor · Uppdaterad 26 aug. 2026 · NCT05281471

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
RekryterarFas 1
Ålder 15 och äldre · Alla kön · Uppdaterad 25 aug. 2026 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Riley Hospital for Children, Indianapolis
RekryterarFas 1/2
12 Months – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT04851119

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

  • Indiana University, Indianapolis
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 21 aug. 2026 · NCT07306559

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

  • IU Health North Hospital, Carmel
  • UChicago Medicine Northwest Indiana, Crown Point
  • Goshen Center for Cancer Care, Goshen
  • och 2 fler
Rekryterar
Ålder 35 till 50 · Kvinnor · Uppdaterad 7 aug. 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • IU Health North Hospital, Carmel
  • Northwest Cancer Center - Crown Point, Crown Point
  • UChicago Medicine Northwest Indiana, Crown Point
  • och 13 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 7 aug. 2026 · NCT06580314

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Community Health Network, Indianapolis
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 30 juli 2026 · NCT04657068

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

  • Community Health Network - MD Anderson, Indianapolis
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 juli 2026 · NCT06161025

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

  • UChicago Medicine - Northwest Indiana, Crown Point
  • Fort Wayne Medical Oncology and Hematology, Inc, Fort Wayne
  • Community Health Network, Inc, Indianapolis
  • och 3 fler
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 6 juli 2026 · NCT04389632

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

  • Indiana University, Indianapolis
RekryterarFas 3
Ålder 18 och äldre · Kvinnor · Uppdaterad 2 juli 2026 · NCT06819007

Integrated Cancer Repository for Cancer Research

  • Parkview Research Center, Fort Wayne
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 19 till 110 · Alla kön · Uppdaterad 29 juni 2026 · NCT02012699

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

  • Fort Wayne Medical Oncology and Hematology, Fort Wayne
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 1 apr. 2026 · NCT05735080

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Baptist Floyd, New Albany
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 40 och äldre · Alla kön · Uppdaterad 20 jan. 2026 · NCT05366881

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.